
One Home for Sites
A neutral aggregator, connector, and communicator for sites to manage key systems and tasks across clinical trials.
Overview
One Home for Sites is a platform designed to streamline site operations in clinical trials by acting as a neutral aggregator, connector, and communicator of key systems and tasks. This solution addresses the proliferation of clinical trial technologies that complicate site operations, enabling investigators to spend more time with patients rather than navigating multiple systems.
This system is particularly beneficial in transforming the site experience, as it provides a unified platform for accessing and managing the numerous technologies in use across various sponsors and trials. According to industry analysis, it holds the potential to improve patient outcomes by reducing the administrative burden that often leads to trials being declined.
Key Features and Benefits:
- Single Sign-On: Simplifies the process of accessing multiple systems with one login.
- Study Organization: Aggregates study-related tasks and communications under one roof.
- Enhanced Communication: Improves coordination between sites and sponsors, expediting trial start-ups and closures.
- Neutrality and Flexibility: Supports existing tech stacks without requiring changes to vendor commitments.
The platform is not only about improving operational efficiency; it is about transforming the role of sites in the clinical trial process by offering a singular, cohesive environment that bridges multiple sponsors and technology vendors' efforts. This integration is crucial as the industry encounters a significant rise in clinical R&D spending and increased study timelines.
IQVIA invites sponsors, CROs, and tech partners to join this movement to simplify the clinical trial landscape, emphasizing that a collaborative, industry-wide approach is essential to drive positive outcomes for sites and, ultimately, patients.

